1-3 of 3
Allan S. Jaffe
Close
Sort by
Journal Articles

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay

Clinical Trials & Observations
Eli Muchtar, Shaji K. Kumar, Morie A. Gertz, Martha Grogan, Omar F. AbouEzzeddine, Allan S. Jaffe, Angela Dispenzieri
Journal: Blood
Blood (2019) 133 (7): 763–766.
https://doi.org/10.1182/blood-2018-10-875252
Published: 2019
Includes: Supplemental data
Journal Articles

Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Angela Dispenzieri, MD, Amy K. Saenger, M.D., Shaji K. Kumar, MD, Morie A. Gertz, M.D., Martha Q Lacy, MD, Francis Buadi, MD, Suzanne R Hayman, MD, Nelson Leung, MD, Steven R Zeldenrust, MD, PhD, Arleigh McCurdy, MD, Robert Kyle, MD, MACP, David Dingli, M.D., Ph.D., Prashant Kapoor, MD, Yi Lin, MDPhD, Stephen J. Russell, MD, PhD, Ronald S. Go, MD, Allan S. Jaffe, M.D.
Journal: Blood
Blood (2013) 122 (21): 3095.
https://doi.org/10.1182/blood.V122.21.3095.3095
Published: 2013
Journal Articles

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

Clinical Trials & Observations
Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, Martha Q. Lacy, Mary F. Burritt, Terry M. Therneau, Joseph P. McConnell, Mark R. Litzow, Dennis A. Gastineau, Ayalew Tefferi, David J. Inwards, Ivana N. Micallef, Stephen M. Ansell, Luis F. Porrata, Michelle A. Elliott, William J. Hogan, S. Vincent Rajkumar, Rafael Fonseca, Philip R. Greipp, Thomas E. Witzig, John A. Lust, Steven R. Zeldenrust, Denise S. Snow, Susan R. Hayman, Christopher G. A. McGregor, Allan S. Jaffe
Journal: Blood
Blood (2004) 104 (6): 1881–1887.
https://doi.org/10.1182/blood-2004-01-0390
Published: 2004